Functional experiments showed that PLA2G2A was highly expressed in gliomas, and its downregulation notably reduced tumor cell proliferation, migration, invasion, and growth in vivo, while reversing the epithelial-mesenchymal transition. The gene discussed is PLA2G2A; the disease is neoplasm.